Filters

Latest News

2017-05-18 13:30:05

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to ...

Read More

2017-05-02 07:50:20

Fumie Griego joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General

IFPMA Director-General Thomas Cueni announced today that former PhRMA and Merck KGaA executive, Dr Fumie ...

Read More

2017-04-17 18:00:39

Progress report on biopharmaceutical industry contributions to the global fight against Neglected Tropical Diseases (NTDs)

109 active R&D projects for NTDs, of which over 90% are collaborative involving over 50 ...

Read More

2017-03-09 16:32:44

EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations for physicians on switching decisions regarding biosimilars”.

Switching describes a physician’s decision to exchange one product that a patient receives for another. ...

Read More

2017-02-28 07:57:57

IFPMA launches new policy principles and report on Rare Disease Day 2017 to benefit patients, healthcare and society

New set of policy principles outlines critical elements for a global framework on rare disease ...

Read More

2017-02-10 09:30:19

IFPMA launches its 2017 facts & figures report

Geneva, 10 February 2017 – IFPMA has just published its 2017 facts & figures report ...

Read More

2017-02-09 14:00:33

Leadership rotation at Fight the Fakes, the worldwide campaign to protect people from fake medicines

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its role as secretariat of Fight ...

Read More

Latest Statement

2017-05-29 09:01:04

WHO WHA 70 item 13.6 Member State mechanism on SSFFC

WHA70 agenda item 13.6  Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products Delivered by Cyntia Genolet, Manager, Regulatory and Health Policy ...

Read More

2017-05-27 10:35:37

WHO WHA 70 agenda item 13.3 Addressing the global shortage of, and access to, medicines and vaccines

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

2017-05-25 16:20:07

WHO WHA 70 item 12.5 Review of the Pandemic Influenza Preparedness Framework

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

2017-05-24 17:33:48

WHO WHA 70 Item A70/12 Antimicrobial resistance

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

2017-05-23 06:56:40

IFPMA Statement on Appointment of Dr Tedros as Director-General of the World Health Organization

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

2017-05-11 08:48:32

IFPMA recommends WHO Fair Pricing Forum outcomes focus on feasible areas for collaboration where there is broad consensus

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

2017-03-27 15:42:51

Delivered at the 21st WHO Expert Committee on the Selection and Use of Essential Medicines

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

The Beam Alliance - Small Biopharma companies from Europe are at the forefront of the battle vs #DrugResistantInfections @AllianceBEAM
2 1
  @IFPMA
RT @plus_socialgood: #Fakemeds are a threat to patients worldwide. To stop them we need integrated multi-stakeholder approaches: https://t.
4
  @IFPMA
Your role matters in fighting #resistance download & share infographics by @biomerieux_inc @MyRoleMatters https://t.co/U63XD8RLFS
3
  @IFPMA
We believe in collaboration & dialogue to address falsified #medicines. Learn more about our activities https://t.co/FPIuRZHOKb #WHA70
  @IFPMA